丁嵩,何奔

• 1:上海交通大学医学院附属仁济医院心内科

摘要(Abstract)：

<正>急性ST段抬高心肌梗死(ST-elevation myocardial infarction,STEMI)再灌注治疗的获益取决于患者总的缺血时间和再灌注自身的有效性。尽早溶栓和经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)是开通梗死相关血管的有效方法。然而,心外膜血流并不等同于心肌灌注,并且,不是所有TIMI血流Ⅲ级的患者在接受PCI术后就

关键词(KeyWords)： 急性ST段抬高心肌梗死;经皮冠状动脉介入治疗;心肌;再灌注

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 丁嵩,何奔

参考文献(References)：

• [1]Hamm CW,Bassand JP,Agewall S,et al.ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:The Task Force for the management of acute coronary syndromes(ACS)in patients presenting without persistent ST-segment elevation of the European Society of Cardiology(ESC).Eur Heart J,2011,32:2999-3054.
• [2]Giugliano RP,Sabatine MS,Gibson CM,et al.Combined assessment of thrombolysis in myocardial infarction flow grade,myocardial perfusion grade,and ST-segment resolution to evaluate epicardial and myocardial reperfusion.Am J Cardiol,2004,93:1362-1367.
• [3]Schrder R.Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction.Circulation,2004,110:e506-510.
• [4]TIMI Study Group.The Thrombolysis in Myocardial Infarction(TIMI)trial.N Engl J Med,1985,312:932-936.
• [5]Gibson CM,Cannon CP,Daley WL,et al.TIMI frame count:a quantitative method of assessing coronary artery flow.Circulation,1996,93:879-888.
• [6]Gibson CM,Cannon CP,Murphy SA,et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.Circulation,2000,101:125-130.
• [7]van't Hof AW,Liem A,Suryapranata H,et al.Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction:myocardial blush grade:Zwolle Myocardial Infarction Study Group.Circulation,1998,97:2302-2306.
• [8]Ding S,Pu J,Qiao ZQ,et al.TIMI myocardial perfusion frame count:a new method to assess myocardial perfusion and its predictive value for short-term prognosis.Catheter Cardiovasc Interv,2010,75:722-732.
• [9]Korosoglou G,Haars A,Michael G,et al.Quantitative evaluation of myocardial blush to assess tissue level reperfusion in patients with acute ST-elevation myocardial infarction:incremental prognostic value compared with visual assessment.Am Heart J,2007,153:612-620.
• [10]Shen LH,Wan F,Shen L,et al.Pharmacoinvasive therapy for ST elevation myocardial infarction in China:a pilot study.J Thromb Thrombolysis,2012,33:101-108.
• [11]Pu J,Ding S,Shan P,et al.Comparison of epicardial and myocardial perfusions after primary coronary angioplasty for STelevation myocardial infarction in patients under and over 75 years of age.Aging Clin Exp Res,2010,22:295-302.
• [12]Pu J,Shan P,Ding S,et al.Gender differences in epicardial and tissue-level reperfusion in patients undergoing primary angioplasty for acute myocardial infarction.Atherosclerosis,2011,215:203-208.
• [13]Ge H,Pu J,Ding S,et al.Value of TIMI myocardial perfusion frame count for prediction of microvascular dysfunction in reperfused STEMI patients,view of cardiac magnetic resonance early after reperfusion.Am J Cardiol,2013,111:40B-B.
• [14]Buechel RR,Kaufmann BA,Tobler D,et al.Non-invasive nuclear myocardial perfusion imaging improves the diagnostic yield of invasive coronary angiography.Eur Heart J Cardiovasc Imaging,2015,16:842-847.
• [15]Qayyum AA,Kastrup J.Measuring myocardial perfusion:the role of PET,MRI and CT.Clin Radiol,2015,70:576-584.
• [16]Bekkers SC,Smulders MW,Passos VL,et al.Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging.Eur Radiol,2010,20:2572-2578.
• [17]Kidambi A,Mather AN,Motwani M,et al.The effect of microvascular obstruction and intramyocardial hemorrhage on contractile recovery in reperfused myocardial infarction:insights from cardiovascular magnetic resonance.J Cardiovasc Magn Reson,2013,15:58.
• [18]Abdelmoneim SS,Dhoble A,Bernier M,et al.Quantitative myocardial contrast echocardiography during pharmacological stress for diagnosis of coronary artery disease:a systematic review and meta-analysis of diagnostic accuracy studies.Eur J Echocardiogr,2009,10:813-825.
• [19]Ito H.Myocardial contrast echocardiography after myocardial infarction.Curr Cardiol Rep,2012,14:350-358.
• [20]Rocchi G,Kasprzak JD,Galema TW,et al.Usefulness of power Doppler contrast echocardiography to identify reperfusion after acute myocardial infarction.Am J Cardiol,2001,87:278-282.
• [21]Villanueva FS,Klibanov A,Wagner WR.Microbubbleendothelial cell interactions as a basis for assessing endothelial function.Echocardiography,2002,19:427-438.
• [22]Fujii H,Li SH,Wu J,et al.Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair.Eur Heart J,2011,32:2075-2084.
• [23]Burzotta F,Trani C,Romagnoli E,et al.Manual thrombusaspiration improves myocardial reperfusion:the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty(REMEDIA)trial.J Am Coll Cardiol,2005,46:371-376.
• [24]Galiuto L,Garramone B,Burzotta F,et al.Thrombus aspiration reduces microvascular obstruction after primary coronary intervention:a myocardial contrast echocardiography substudy of the REMEDIA Trial.J Am Coll Cardiol,2006,48:1355-1360.
• [25]Burzotta F,Testa L,Giannico F,et al.Adjunctive devices in primary or rescue PCI:a meta-analysis of randomized trials.Int J Cardiol,2008,123:313-321.
• [26]Vlaar PJ,Svilaas T,van der Horst IC,et al.Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study(TAPAS):a 1-year follow-up study.Lancet,2008,371:1915-1920.
• [27]Micari A,Belcik TA,Balcells EA,et al.Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.Am J Cardiol,2005,96:1410-1415.
• [28]Kunadian V,Zorkun C,Williams SP,et al.Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.J Thromb Thrombolysis,2008,26:234-242.
• [29]Aung Naing K,Li L,Su Q,et al.Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.Cochrane Database Syst Rev,2013,6:CD009503.
• [30]Petronio AS,De Carlo M,Ciabatti N,et al.Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine.Am Heart J,2005,150:1015.
• [31]Thiele H,Schindler K,Friedenberger J,et al.Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention:the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.Circulation,2008,118:49-57.
• [32]Ohno Y,Minatoguchi S,Uno Y,et al.Nicorandil reduces myocardial infarct size by opening the K(ATP)channel in rabbits.Int J Cardiol,1997,62:181-190.
• [33]Ota S,Nishikawa H,Takeuchi M,et al.Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction:Sigmart Multicenter Angioplasty Revascularization Trial(SMART).Circ j,2006,70:1099-1104.
• [34]Rezkalla SH,Dharmashankar KC,Abdalrahman IB,et al.Noreflow phenomenon following percutaneous coronary intervention for acute myocardial infarction:incidence,outcome,and effect of pharmacologic therapy.J Interv Cardiol,2010,23:429-436.
• [35]Su Q,Li L,Liu Y.Short-term effect of verapamil on coronary noreflow associated with percutaneous coronary intervention in patients with acute coronary syndrome:a systematic review and meta-analysis of randomized controlled trials.Clin Cardiol,2013,36:E11-E16.
• [36]Zhao S,Qi G,Tian W,et al.Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention:a meta-analysis.J Interv Cardiol,2014,27:356-364.
• [37]孙宇珺,周雯,丁嵩,等.经靶向灌注导管在冠脉靶病变远端给予替罗非班对急性冠脉综合征患者心肌灌注的影响.中国介入心脏病学杂志,2015,23:5-10.